Cytiva_Jan2022_mRNAVaccinesANewEra - 15

mRNA VACCINES: A NEW ERA OF BIOTHERAPEUTIC DEVELOPMENT
tools you'll need to be successful, look for
experienced and knowledgeable vendors that
have already begun to equip their arsenal with
products designed to accommodate the mRNA
workflow from idea all the way to injection.
Doing so will position you at the forefront of this
biopharmaceutical revolution, where mRNA is
emerging as an unstoppable force in fighting
and preventing disease around the world. n
References
1. Center for Disease Control. (May 7, 2021). Effectiveness
of Pfizer-BioNTech and Moderna Vaccines Against
COVID-19 Among Hospitalized Adults Aged >65 Years
- United States, January-March 2021. https://www.cdc.
gov/mmwr/volumes/70/wr/mm7018e1.htm
2. Kwon, Diana. (November 25, 2020). The Promise
of mRNA Vaccines. The Scientist. https://www.
the-scientist.com/news-opinion/the-promise-of-mrnavaccines-68202
3.
Globe News Wire. (June 23, 2021). Global mRNA
Vaccines Market to Reach $127.3 Billion by
2027. https://www.globenewswire.com/newsrelease/2021/06/23/2251546/0/en/Global-mRNAVaccines-Market-to-Reach-127-3-Billion-by-2027.html
4.
Colarossi, Natalie. (July 18, 2020). How long it took to
develop 12 other vaccines in history. Business Insider.
https://www.businessinsider.com/how-long-it-took-todevelop-other-vaccines-in-history-2020-7#influenza-5
Additional
Resources...
mRNA Manufacturing
Strategies
Solutions for large-scale
production of mRNA molecules.
Learn More
5. Verga, David. (February 10, 2021). mRNA and the future
of vaccine manufacturing. PATH. https://www.path.org/
articles/mrna-and-future-vaccine-manufacturing/
6. Trefis Team, Great Speculations. How Is Moderna's
Vaccine Production Scaling Up?. Forbes. https://www.
forbes.com/sites/greatspeculations/2021/01/07/
how-is-modernas-vaccine-production-scalingup/?sh=5be1a52b6e68
7.
Langreth, Robert. (December 3, 2020). Pfizer Scaled
Back 2020 COVID-19 Vaccine Production Targets From
100 Million to 50 Million Doses. Time. https://time.
com/5917847/pfizer-cut-covid-19-vaccine-targets/
8. Akron Biotech. (October 2020). Akron Biotech Acquires
Cytiva FlexFactory for the Manufacture of Plasmid
DNA. https://www.akronbiotech.com/newsroom/
akron-biotech-acquires-cytiva-flexfactory-for-themanufacture-of-plasmid-dna/
9.
Precision Nanosystems. Areas of Interest: Messenger
RNA. https://www.precisionnanosystems.com/
workflows/payloads/mrna
10. Precision Nanosystems. (2020). Accelerating the
Development of Transformative Nanomedicines with
NxGen™ Microfluidics Technology. https://www.
precisionnanosystems.com/docs/default-source/
pni-files/app-notes/model-mrna-lnp-therapeutic5139
4821a9754311bfebb59ab1e88149.f?sfvrsn=125053a8
_0therapeutic51394821a9754311bfebb59ab1e88149.
pdf?sfvrsn=125053a8_0
11. Chakamba, Rumbi. (May 13, 2021). The cold chain
storage challenge. Devex. https://www.devex.com/
news/the-cold-chain-storage-challenge-99869
12. Cytiva. Meet the SA25 Aseptic Filling Workcell. https://
vanrx.com/products/sa25-aseptic-filling-workcell/
GENengnews.com | 15
Cytiva_Jan2022_mRNAVaccinesANewEra

Table of Contents for the Digital Edition of Cytiva_Jan2022_mRNAVaccinesANewEra
